An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens
scientific article published on 15 October 2018
Author/s
author: Josep Nomdedeu, M. Carmen Chillón, Mar Tormo, Javier de la Serna, Josep-Maria Ribera, Miguel A Sanz, Isabel Krsnik, Aleksandra Hołowiecka-Goral, Marta Sobas, Manuel Pérez-Encinas
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.